Looking Closely at the Growth Curve for 10x Genomics Inc. (TXG) – News Heater
Home  »  Trending   »  Looking Closely at the Growth Curve for 10x Genomi...

Looking Closely at the Growth Curve for 10x Genomics Inc. (TXG)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

10x Genomics Inc. (NASDAQ:TXG) went down by -7.89% from its latest closing price compared to the recent 1-year high of $208.99. The company’s stock price has collected -18.46% of loss in the last five trading sessions. Press Release reported on 08/31/21 that 10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Is It Worth Investing in 10x Genomics Inc. (NASDAQ :TXG) Right Now?

Opinions of the stock are interesting as 7 analysts out of 10 who provided ratings for 10x Genomics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $197.63, which is $48.0 above the current price. TXG currently public float of 86.20M and currently shorts hold a 3.61% ratio of that float. Today, the average trading volume of TXG was 645.50K shares.

TXG’s Market Performance

TXG stocks went down by -18.46% for the week, with a monthly drop of -2.88% and a quarterly performance of -18.15%, while its annual performance rate touched 28.75%. The volatility ratio for the week stands at 5.02% while the volatility levels for the past 30 days are set at 4.16% for 10x Genomics Inc.. The simple moving average for the period of the last 20 days is -9.10% for TXG stocks with a simple moving average of -10.04% for the last 200 days.

Analysts’ Opinion of TXG

Many brokerage firms have already submitted their reports for TXG stocks, with BofA Securities repeating the rating for TXG by listing it as a “Neutral.” The predicted price for TXG in the upcoming period, according to BofA Securities is $180 based on the research report published on September 14th of the current year 2021.

Goldman gave a rating of “Neutral” to TXG, setting the target price at $150 in the report published on December 02nd of the previous year.

TXG Trading at -11.34% from the 50-Day Moving Average

After a stumble in the market that brought TXG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.51% of loss for the given period.

Volatility was left at 4.16%, however, over the last 30 days, the volatility rate increased by 5.02%, as shares sank -2.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.47% lower at present.

During the last 5 trading sessions, TXG fell by -18.46%, which changed the moving average for the period of 200-days by +10.53% in comparison to the 20-day moving average, which settled at $171.02. In addition, 10x Genomics Inc. saw 9.94% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TXG starting from Saxonov Serge, who sale 15,000 shares at the price of $188.42 back on Sep 07. After this action, Saxonov Serge now owns 898,468 shares of 10x Genomics Inc., valued at $2,826,232 using the latest closing price.

Hindson Benjamin J., the See Remarks of 10x Genomics Inc., sale 41,666 shares at $177.50 during a trade that took place back on Sep 01, which means that Hindson Benjamin J. is holding 47,117 shares at $7,395,887 based on the most recent closing price.

Stock Fundamentals for TXG

Equity return is now at value -65.00, with -51.60 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Is Nevro Corp. (NVRO) a Keeper?

Nevro Corp. (NYSE:NVRO) went down by -1.96% from its latest closing price compared to the recent 1-year high of $188.14. The company’s stock price has

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam